Suppressive functions of activated B cells in autoimmune diseases reveal the dual roles of Toll‐like receptors in immunity
Vicky Lampropoulou(National and Kapodistrian University of Athens), Simon Fillatreau(Hôpital Necker-Enfants Malades), Pierre Boudinot(Université de Versailles Saint-Quentin-en-Yvelines), Patrícia Neves(German Rheumatism Research Centre), Elisabeth Calderón‐Gómez(German Rheumatism Research Centre), Toralf Roch(Charité - Universitätsmedizin Berlin), Ping Shen(Humboldt-Universität zu Berlin), Stephen M. Anderton(Centre for Inflammation Research), Ulrik Stervbo(Humboldt-Universität zu Berlin)
Cited by 125
Related Papers
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
|Nucleic Acids Research|2017|1.7k
B cells regulate autoimmunity by provision of IL-10
|Nature Immunology|2002|1.6k
Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation
|Cell Metabolism|2016|1.5k
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases
|Nature|2014|1k
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
|The Journal of Experimental Medicine|2012|651